DELHI/MUMBAI (Reuters) - India's Torrent Pharmaceuticals is in talks with private equity funds CVC Capital Partners and Bain Capital to raise up to $1.5 billion to bid for India's Cipla, according to ...
BENGALURU, June 21 (Reuters) - Japan's Takeda Pharmaceutical (4502.T), opens new tab gave India's Sun Pharmaceutical (SUN.NS), opens new tab and Cipla (CIPL.NS), opens new tab the rights to ...
Mumbai, India-based Cipla Inc. pharmaceuticals will establish a U.S. headquarters at Independence Place in Warren.Mumbai, India-based Cipla Inc. pharmaceuticals will establish a U.S. headquarters at ...
US pharma major Cipla is in focus after the US Food and Drug Administration flagged serious compliance issues at its partner Pharmathen's manufacturing facility in Greece. The regulator highlighted ...
US drugmaker Eli Lilly has struck a deal with domestic drug giant Cipla Ltd to widen the reach of its blockbuster weight loss drug tirzepatide, doubling down on India’s booming market ahead of an ...
Torrent hopes to raise up to $1.5 bln for Cipla bid Cipla bid could be India's biggest pharma deal Deal could be worth as much as $7 billion - Bernstein Torrent and Blackstone (BX.N), opens new tab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback